PERRONE, FRANCESCO
PERRONE, FRANCESCO
SCIENZE MEDICHE
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients
2017-01-01 Kim, Lucia; Saieg, Mauro; Di Maio, Massimo; Gallo, Ciro; Butts, Charles; Ciardiello, Fortunato; Feld, Ronald; Cheng, Dengxiao; Gebbia, Vittorio; Burgio, Marco Angelo; Alam, Yasmin; Signoriello, Simona; Rossi, Antonio; Leighl, Natasha; Maione, Paolo; Morabito, Alessandro; Liu, Geoffrey; Tsao, Ming-Sound; Perrone, Francesco; Gridelli, Cesare*
Deficiencies in health-related quality of life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016
2018-01-01 Marandino, L; La Salvia, A; Sonetto, C; De Luca, E; Pignataro, D; Zichi, C; Di Stefano, R; Ghisoni, E; Lombardi, P; Mariniello, A; Reale, M; Trevisi, E; Leone, G; Muratori, L; Marcato, M; Bironzo, P; Novello, S; Aglietta, M; Scagliotti, G; Perrone, F; Di Maio, M
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients | 2017 | Kim, Lucia; Saieg, Mauro; Di Maio, Massimo; Gallo, Ciro; Butts, Charles; Ciardiello, Fortunato; Feld, Ronald; Cheng, Dengxiao; Gebbia, Vittorio; Burgio, Marco Angelo; Alam, Yasmin; Signoriello, Simona; Rossi, Antonio; Leighl, Natasha; Maione, Paolo; Morabito, Alessandro; Liu, Geoffrey; Tsao, Ming-Sound; Perrone, Francesco; Gridelli, Cesare* | |
Deficiencies in health-related quality of life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016 | 2018 | Marandino, L; La Salvia, A; Sonetto, C; De Luca, E; Pignataro, D; Zichi, C; Di Stefano, R; Ghisoni, E; Lombardi, P; Mariniello, A; Reale, M; Trevisi, E; Leone, G; Muratori, L; Marcato, M; Bironzo, P; Novello, S; Aglietta, M; Scagliotti, G; Perrone, F; Di Maio, M |